Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Astragaloside IV prevents acute myocardial infarction by inhibiting the TLR4/MyD88/NF‐κB signaling pathway
Hui Shi, Peng Zhou, Ge Gao, et al.
Journal of Food Biochemistry (2021) Vol. 45, Iss. 7
Open Access | Times Cited: 62

Showing 1-25 of 62 citing articles:

Signaling pathways and targeted therapy for myocardial infarction
Qing Zhang, Lu Wang, Shiqi Wang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 486
The traditional Chinese medicines treat chronic heart failure and their main bioactive constituents and mechanisms
Jie Chen, Xiao‐Hong Wei, Qian Zhang, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 5, pp. 1919-1955
Open Access | Times Cited: 56
Biological active ingredients of Astragali Radix and its mechanisms in treating cardiovascular and cerebrovascular diseases
Man Li, Bing Han, Huan Zhao, et al.
Phytomedicine (2022) Vol. 98, pp. 153918-153918
Closed Access | Times Cited: 69
MyD88 and Its Inhibitors in Cancer: Prospects and Challenges
Jiali Song, Yuying Li, Ke Wu, et al.
Biomolecules (2024) Vol. 14, Iss. 5, pp. 562-562
Open Access | Times Cited: 10
Lactucin alleviates liver fibrosis by regulating the TLR4-MyD88-MAPK/NF-κB signaling pathway through intestinal flora
Liping Zhu, Bo Lv, Yuefeng Gao, et al.
Archives of Biochemistry and Biophysics (2025), pp. 110341-110341
Closed Access | Times Cited: 1
Kaempferol‐3‐ O ‐rutinoside exerts cardioprotective effects through NF‐ κ B/NLRP3/Caspase‐1 pathway in ventricular remodeling after acute myocardial infarction
Fang Hua, Jing Ya Li, Meng Zhang, et al.
Journal of Food Biochemistry (2022) Vol. 46, Iss. 10
Open Access | Times Cited: 30
Review on the protective mechanism of astragaloside IV against cardiovascular diseases
Chunkun Yang, Qingquan Pan, Kui Ji, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 21
The Molecular Basis of the Anti-Inflammatory Property of Astragaloside IV for the Treatment of Diabetes and Its Complications
Lin Li, Yuwei Zhang, Yudan Luo, et al.
Drug Design Development and Therapy (2023) Vol. Volume 17, pp. 771-790
Open Access | Times Cited: 19
Integrative transcriptomics and proteomics analysis reveal the protection of Astragaloside IV against myocardial fibrosis by regulating senescence
Lipeng Shi, Jingwei Deng, Jun He, et al.
European Journal of Pharmacology (2024) Vol. 975, pp. 176632-176632
Open Access | Times Cited: 8
Astragaloside Ⅳ negatively regulates Gpr97-TPL2 signaling to protect against hyperhomocysteine-exacerbated sepsis associated acute kidney injury
Jingge Xu, Zhiyu Zhang, Dongwen Ren, et al.
Phytomedicine (2024) Vol. 125, pp. 155346-155346
Closed Access | Times Cited: 5
Research progress on the antitumor effects of astragaloside IV
Ruixi Zhou, Tiankang Guo, Junliang Li
European Journal of Pharmacology (2022) Vol. 938, pp. 175449-175449
Closed Access | Times Cited: 19
Cardioprotective Effects of Tetrahydropalmatine on Acute Myocardial Infarction in Rats
Bing-Jing Han, Guiyun Cao, Li-Ying Jia, et al.
The American Journal of Chinese Medicine (2022) Vol. 50, Iss. 07, pp. 1887-1904
Closed Access | Times Cited: 17
Eupatilin alleviates inflammatory response after subarachnoid hemorrhage by inhibition of TLR4/MyD88/NF‐κB axis
Yu Hong, Shiqing He, Qin Zou, et al.
Journal of Biochemical and Molecular Toxicology (2023) Vol. 37, Iss. 5
Open Access | Times Cited: 10
Recent pharmacological advances in the treatment of cardiovascular events with Astragaloside IV
Zehui Xu, Houle Zhou, Yihan Zhang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115752-115752
Open Access | Times Cited: 10
LuQi Formula Ameliorates Pressure Overload-induced Heart Failure by Regulating Macrophages and Regulatory T cells
Xinting Wang, Qian Liu, Peipei Cheng, et al.
Phytomedicine (2025), pp. 156527-156527
Closed Access
Nephroprotective effects of substances of medicine food homology and traditional Chinese medicine phytochemicals against acute kidney injury
Ling Chen, Yanyan Deng, Jing Hu, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Norisoboldine Alleviates Isoproterenol‐Induced Myocardial Ischemic Injury via the TLR4–MyD88‐Dependent NF‐κB Activation Pathway and Modulation of L‐Type Calcium Channels
Xin Zhang, Xinliu Wang, Yuanyuan Wang, et al.
Clinical and Experimental Pharmacology and Physiology (2025) Vol. 52, Iss. 4
Closed Access
Stachydrine hydrochloride reduces NOX2 activity to suppress oxidative stress levels to improve cardiac insufficiency
Mengwei Fu, Shuting Guo, Songru Yang, et al.
Phytomedicine (2025) Vol. 140, pp. 156621-156621
Closed Access
Therapeutic potential and mechanistic insights of astragaloside IV in the treatment of arrhythmia: a comprehensive review
Mei-Lian Chen, Binlan Fu, Hao Zhou, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Anti-fibrosis effect of astragaloside IV in animal models of cardiovascular diseases and its mechanisms: a systematic review
Shiyu Zhang, Shijie Li, Xue Li, et al.
Pharmaceutical Biology (2025) Vol. 63, Iss. 1, pp. 250-263
Open Access
Quercetin in Shengxian Decoction exhibits anti-ferroptosis protective roles in a myocardial infarction model via targeting DPP4/ HMOX1, based on network pharmacology and molecular docking
Yu Zhai, J. F. Fu, Jianfei Yang, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Modulation of NLRP3 Inflammasome: Advantages of Chinese Herbal Medicine in Treating Myocardial Ischemia/Reperfusion Injury
Yihang Du, Chenglin Duan, Xiaohan Zhang, et al.
The American Journal of Chinese Medicine (2025) Vol. 53, Iss. 03, pp. 737-769
Closed Access
Astragaloside IV Regulates Insulin Resistance and Inflammatory Response of Adipocytes via Modulating MIR-21/PTEN/PI3K/AKT Signaling
Xuxi Guo, Taoqing Yin, Dongni Chen, et al.
Endocrine Metabolic & Immune Disorders - Drug Targets (2023) Vol. 23, Iss. 12, pp. 1538-1547
Closed Access | Times Cited: 9
Cyanidin prevents cardiomyocyte apoptosis in mice after myocardial infarction
Gang Deng, Qing Ouyang, Yongzheng Yang, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 8, pp. 5883-5898
Closed Access | Times Cited: 3
The recent advance and prospect of natural source compounds for the treatment of heart failure
Xingjuan Chen, Siyuan Liu, Siming Li, et al.
Heliyon (2024) Vol. 10, Iss. 5, pp. e27110-e27110
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top